Increased Galectin-1 Expression in Thymic Epithelial Tumors

Jonathan Riess, Christina S. Kong, Robert B. West, Sukhmani K. Padda, Joel W. Neal, Heather A. Wakelee, Quynh Thu Le

Research output: Contribution to journalArticle

1 Scopus citations


Thymic malignancies are rare tumors where lack of preclinical models adversely affect development of new therapies. Galectin-1 is an important protein in cancer involved in maintaining an immunosuppressive environment. This study examined galectin-1 expression in a large thymic epithelial tumor issue microarray and found elevated expression compared to benign thymus controls. Galectin-1 is a potential therapeutic target in thymic malignancies.

Original languageEnglish (US)
JournalClinical Lung Cancer
StatePublished - Jan 1 2019


  • Thymic malignancy
  • Tumor microenvironment

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Fingerprint Dive into the research topics of 'Increased Galectin-1 Expression in Thymic Epithelial Tumors'. Together they form a unique fingerprint.

  • Cite this

    Riess, J., Kong, C. S., West, R. B., Padda, S. K., Neal, J. W., Wakelee, H. A., & Le, Q. T. (2019). Increased Galectin-1 Expression in Thymic Epithelial Tumors. Clinical Lung Cancer.